No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Melflufen plus dexamethasone showed superior progression-free survival over standard of care in multiple myeloma refractory to lenalidomide

byKathleen Lau

January 27, 2022

in StudyGraphics

Reading Time: 1 min read

Shorter antibiotic course effective in children with community acquired pneumonia

RelatedReports

Variation noted across pre- and post-marketing studies for FDA approved devices

Hematology

FDA grants priority review for iberdomide-based myeloma regimen

March 6, 2026

Majority of pediatric medication-related visits to emergency department are preventable

Oncology

Palbociclib as adjunct maintenance therapy prolongs progression-free survival in some types of metastatic breast cancer

January 28, 2026

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Weekly Rewinds

2 Minute Medicine Rewind

January 13, 2026

Shorter overall survival among patients with monoclonal gammopathy of undetermined significance

Chronic Disease

Pre-maintenance positron emission tomography/computed tomography and bone marrow multiparameter flow cytometry are important for prognostication in multiple myeloma treated with daratumumab

January 13, 2026

Risk of myocarditis after receiving mRNA-based COVID-19 vaccines

Cancer to surpass heart disease as leading cause of death in the U.S. for higher-income persons

Longer onset-to-treatment time for subarachnoid hemorrhage is associated with increased 12-month all-cause mortality

Bystander intervention may improve survival after exercise-related sudden cardiac arrest

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports